Zheng Hao

Zheng Hao

Auto-generated profile, based on publicly available information

Zheng Hao

Department of Environmental Health, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2018 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
ZHZheng Hao
Zheng Hao
SHSi Hu
Si Hu
ZLZheng Liu
Zheng Liu
WSWeixin Song
Weixin Song
YZYeyu Zhao
Yeyu Zhao
MLMeihua Li
Meihua Li

31 December 2018 in Translational Neuroscience
Verified
Journal Article
Open access
PDF file
NYNianzu Yu
Nianzu Yu
SHSi Hu
Si Hu
ZHZheng Hao
Zheng Hao
Present investigation aims to explore the protective effect of stachydrine against traumatic brain injury (TBI) and also investigate the molecular mechanism of its action. TBI was induced by the fall a hammer (450 g) from the height of 1.5 m. and later stachydrine was administered for 2 weeks starting 2 hr after the induction of TBI. Effect of stachydrine was determined by estimating modified neurological severity score (mNSS), percentage of water content in the brain and cognitive dysfunction in TBI rats. Moreover western blot assay, histopathology and enzyme linked immunosorbent assay (ELISA) tests were used to determine the effect of stachydrine on TBI injured rats. Result of the report suggests that stachydrine reduces the mNSS and percentage of water content in the brain and also attenuates the cognitive dysfunction in TBI injured rats. However data of western blot assay reports that stachydrine reduces the expression of PI3K/m-TOR/Akt pathway in the brain tissues of TBI rats. Concentration of interleukin (IL-1β), tumor necrosis factor-α (TNF-α) and interferon gamma (INF-γ) was reduces in stachydrine treated group than TBI group. Moreover expression of Nuclear factor-κB/Toll-like receptor 4 (NF-κB/TLR-4) protein was also decreased in stachydrine treated group than TBI group. Histopathology study on brain tissue reveals that the percentage of apoptotic cells was also reduced in stachydrine treated group than TBI group. Data of this investigation concludes that stachydrine protects the neuronal injury by attenuating the phosphatidylinositide 3-kinases/mammalian target of rapamycin/Protein kinase B (PI3K/m-TOR/Akt) and NF-κB/TLR-4 pathway in TBI injured rats.

30 July 2018 in Neurosurgery
Verified
Journal Article
Closed access
SHSi Hu
Si Hu
NYNianZu Yu
NianZu Yu
YLYiYun Li
YiYun Li
ZHZheng Hao
Zheng Hao
ZLZheng Liu
Zheng Liu
MLMei-Hua Li
Mei-Hua Li
BACKGROUND: Understanding the risk factors for the formation of de novo intracranial aneurysms (IAs) is important for patients who have ever suffered a cerebral aneurysm. OBJECTIVE: To estimate the risk factors for the development of a de novo IA to identify which patients need more aggressive surveillance after aneurysm treatment. METHODS: We followed the preferred reporting items for systematic reviews and meta-analyses guidelines and searched the PubMed, CENTRAL, EMBASE, and LILACS databases using the key words cerebral aneurysms, de novo, IAs, risk factors combined using and/or. The search was performed in July 2017.We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using RevMan 5.3 (Cochrane, London, United Kingdom) to evaluate risk factors. Statistical significance was set at P < .05. RESULTS: The analysis included 14 studies involving 6389 patients, of whom 197 patients had de novo IAs. The main risk factors for formation included sex (OR = 1.82, 95% CI [1.30,2.56], P = .0005, female vs male), age <40 yr (OR = 2.96, 95% CI [1.76,4.96], P < .0001), family history (OR = 2.05, 95% CI [1.07,3.93], P = .03), smoking history (OR = 2.73, 95% CI [1.81,4.12], P < .0001), and multiple saccular intracranial aneurysms (sIAs) at first diagnosis (OR = 2.10, 95% CI [1.12,3.91], P = .02), internal carotid artery (ICA) as the initial site (OR = 2.58, 95% CI [1.43,4.68], P = .002). Heterogeneous analysis showed that these I2 were less than 50% and the results were reliable. CONCLUSION: Observational evidence identified multiple clinical and anatomic risk factors for the formation of de novo IAs, including female sex, age <40 yr, family history, smoking history, multiple sIAs at first diagnosis, and IC as the initial site. More aggressive long-term angiographic follow-up with digital subtraction angiography, computed tomography angiography, or magnetic resonance angiography is recommended for these patients.

1 October 2019 in World Neurosurgery
Verified
Journal Article
Closed access
YZYe-Yu Zhao
Ye-Yu Zhao
SCSi-Hai Chen
Si-Hai Chen
ZHZheng Hao
Zheng Hao
HZHua-Xin Zhu
Hua-Xin Zhu
ZXZe-Long Xing
Ze-Long Xing
MLMeihua Li
Meihua Li

15 July 2021 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
HZHao Zheng
Hao Zheng
WYWeizhuo Yi
Weizhuo Yi
ZDZhen Ding
Zhen Ding
ZXZhiwei Xu
Zhiwei Xu
HHHung Chak Ho
Hung Chak Ho
HSHong Su
Hong Su